APA (7th ed.) Citation

Uchibori, K., Inase, N., Araki, M., Kamada, M., Sato, S., Okuno, Y., . . . Katayama, R. (2017). Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer. Nature Portfolio.

Chicago Style (17th ed.) Citation

Uchibori, Ken, Naohiko Inase, Mitsugu Araki, Mayumi Kamada, Shigeo Sato, Yasushi Okuno, Naoya Fujita, and Ryohei Katayama. Brigatinib Combined with Anti-EGFR Antibody Overcomes Osimertinib Resistance in EGFR-mutated Non-small-cell Lung Cancer. Nature Portfolio, 2017.

MLA (8th ed.) Citation

Uchibori, Ken, et al. Brigatinib Combined with Anti-EGFR Antibody Overcomes Osimertinib Resistance in EGFR-mutated Non-small-cell Lung Cancer. Nature Portfolio, 2017.